Post-market Clinical Follow-up (PMCF) Study of the Infinity-Lock Button System for Acromioclavicular Joint Stabilisation
Condition(s) studied
Investigational drug(s) / intervention(s)
Infinity-Lock Button System: Infinity-Lock Button System
Study summary
This is a Post-market Clinical Follow-up Study. It will verify the long-term safety and performance of the Infinity-Lock Button System (ILBS) when used for acute and chronic dislocations of the Acromioclavicular Joint and used as described by the manufacturer's instructions.
Eligibility
Primary outcome measure(s)
- Constant Murley Score (CMS) — 1 year
The primary performance endpoint is the change in the CMS from baseline to 1 year after surgery. Minimum score is 0 maximum is 100 with the better functioning shoulders having a greater number of points. - Device Related or Procedure Related Adverse events — 1 year
device-related and/or procedure-related adverse events up to 1 year after surgery.
Trial sites (4)
| Facility | City | Region | Status |
|---|---|---|---|
| East Kent Hospitals University NHS Foundation Trust, | Canterbury | United Kingdom | Recruiting |
| Barts Health NHS Trust | London | United Kingdom | Recruiting |
| Nottingham University Hospitals | Nottingham | United Kingdom | Recruiting |
| Royal Berkshire NHS Foundation Trust | Reading | United Kingdom | Active Not Recruiting |
More Xiros Ltd trials in the UK
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05397210 on ClinicalTrials.gov ↗ ← All trials in the UK